|
Dr. Norman Barton is currently Executive Vice President and Chief Medical Officer of Ceptor Corporation. Dr. Barton who was formally trained in biological chemistry and internal medicine and is a certified specialist in neurology has had a distinguished career in investigative medicine and in the development of novel therapeutic agents in both the academic and commercial sectors. His many accomplishments include the development of an enzyme replacement therapy for a severely debilitating lipid storage disorder known as Gaucher disease for which he received both the Outstanding and Meritorious Service Medals of the United States Public Health Service. Prior to joining CepTor Dr. Barton served as executive vice president and chief medical officer at Osiris Therapeutics (2002-2004) Biotechnology General Corp (1996-2002) and also served as a physician-scientist and Chief of the Clinical Investigations Section with the Neurological Institute at the National Institutes of Health (1985-1996). Dr. Barton received his M.D. and Ph.D. degrees from Pennsylvania State University and he completed his residency in Internal Medicine at Albany Medical College Hospital and his residency in Neurology at Cornell University New York Hospital.
| 